2020 04 09 21 21 1283 Bio Rad Aacc 2019 400

Bio-Rad Laboratories announced a partnership with South Korean molecular diagnostics company Seegene to develop and commercialize new diagnostic products for diagnosing infectious diseases.

Seegene will provide diagnostic tests for use on Bio-Rad's CFX96 Dx polymerase chain reaction (PCR) detection system, pending clinical development and clearance from the U.S. Food and Drug Administration, Bio-Rad said.

Seegene's assays offer multiplex real-time PCR detection and differentiation, with high sensitivity and specificity of up to seven targets in a single reaction, according to Bio-Rad.

Page 1 of 16
Next Page